Other Information
−Removed: Incorporation by Reference
+Added: Insider Trading Arrangements
+Added: During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities as set forth in the table below.
+Added: Type of Trading Arrangement
+Added: Name and Position
+Added: Adoption/ Termination
+Added: Rule 10b5-1 (1)
+Added: Rule 10b5-1 (2)
+Added: Total Ordinary Shares to be Sold (3)
+Added: Expiration Date
+Added: SVP, Finance & Chief Accounting Officer
+Added: June 14, 2024 X
+Added: December 31, 2025
+Added: (1) Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
+Added: (2) “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
+Added: (3) Represents ordinary shares in the form of American Depositary Shares.
Exhibit Number
+Added: Incorporation by Reference
+Added: Schedule / Form
Articles of Association of Immunocore Holdings plc
−Removed: March 25, 2021
−Removed: Indenture, dated as of February 2, 2024, by and between the Company and U.S.
−Removed: Bank Trust Company,
−Removed: National Association, as Trustee.
−Removed: February 2, 2024
−Removed: Form of Global Note, representing the Company’s 2.50% Convertible Senior Notes due 2030 (included as Exhibit A to the Indenture filed as Exhibit
−Removed: February 2, 2024
Certification by the Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
10 unchanged sentences
Filed herewith.
−Removed: This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing
−Removed: under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
+Added: This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
IMMUNOCORE HOLDINGS PLC
+Added: August 8, 2024
/s/ Bahija Jallal
2 unchanged sentences
(On Behalf of the Registrant and as Principal Executive Officer)
+Added: August 8, 2024
/s/ Brian Di Donato
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.